TP THERAPEUTICS, INC.

Profile

Company Names

TP THERAPEUTICS, INC.

Addresses

6650 LUSK BLVD., SUITE B107, SAN DIEGO, CA 92121

Phone Numbers

858-926-5251

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2013

State Incorporated:

DELAWARE

Total Amount Raised:

$17,979,732.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2015-09-16 
$17,979,732.00 
$18,000,340.00 
$20,608.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BIHUA 
 
CHEN 
DIRECTOR
CORMORANT GLOBAL HEALTHCARE FUND, LP   |  CORMORANT GLOBAL HEALTHCARE OFFSHORE FUND, LTD.   |  APELLIS PHARMACEUTICALS, INC.   |  C4 THERAPEUTICS, INC.   |  CORMORANT PRIVATE HEALTHCARE FUND I, LP   |  TP THERAPEUTICS, INC.   |  TP THERAPEUTICS, INC   |  KEZAR LIFE SCIENCES, INC.   |  ATEA PHARMACEUTICALS, INC.   |  CORMORANT PRIVATE HEALTHCARE OFFSHORE FUND II, LP   |  CORMORANT PRIVATE HEALTHCARE FUND II, LP   |  ATIA VISION, INC.   |  SUPIRA MEDICAL, INC.   |  CORMORANT PRIVATE HEALTHCARE FUND III LP   |  CORMORANT PRIVATE HEALTHCARE OFFSHORE FUND III LP   |  ADONA MEDICAL, INC.   |  BLOSSOMHILL THERAPEUTICS, INC.   |  CORMORANT PRIVATE HEALTHCARE OFFSHORE FUND IV LP   |  CORMORANT PRIVATE HEALTHCARE FUND IV LP   |  TIOGA CARDIOVASCULAR, INC.   |  BIVACOR INC.   |  CHROMA MEDICINE, INC.   |  BIOVENTRIX INC   |  TIGER BIOTHERAPEUTICS INC.   |  CORMORANT PRIVATE HEALTHCARE FUND V LP   |  CORMORANT PRIVATE HEALTHCARE OFFSHORE FUND V LP   |  GRAVITON BIOSCIENCE CORP   |  INTERIUS BIOTHERAPEUTICS, INC.   |  CORMORANT PRIVATE HEALTHCARE FUND VI, LP   |  CORMORANT PRIVATE HEALTHCARE OFFSHORE FUND VI, LP   |  AKURA MEDICAL, INC.
JINGRONG 
JEAN 
CUI 
EXECUTIVE OFFICER, DIRECTOR
TP THERAPEUTICS, INC.
KENNETH 
 
FONG 
DIRECTOR
GENBEN LIFESCIENCES CORP   |  APEXIGEN, INC.   |  TP THERAPEUTICS, INC.   |  TP THERAPEUTICS, INC   |  TP THERAPEUTICS, INC.
GEORGE 
J. 
LEE 
DIRECTOR
APPLIED BIOCODE, INC.   |  TP THERAPEUTICS, INC.   |  REVMAB BIOSCIENCES, INC.
YISHAN 
 
LI 
EXECUTIVE OFFICER, DIRECTOR
GENBEN LIFESCIENCES CORP   |  TP THERAPEUTICS, INC   |  TP THERAPEUTICS, INC.   |  TP THERAPEUTICS, INC.   |  BLOSSOMHILL THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2016-03-21
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-09-16 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#